GenMark Diagnostics to offer 10M shares; Reconciled user fee bill comes up for House vote;

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Molecular diagnostics firm GenMark Diagnostics ($GNMK) is planning a public offering of 10 million shares, looking to use the money raised to develop more test offerings and expand its global reach. More

> CareFusion ($CFN) has signed a deal to link its Alaris infusion pumps to Epic's electronic medical reporting platform, allowing doctors to track issues and reduce errors. Item

> Boehringer Ingelheim has launched a study to evaluate whether Pradaxa is more effective than warfarin in patients with mechanical heart valves. News

> Cardiac Science, a Puget Sound, WA-area maker of automated external defibrillators and electrocardiac devices, has hired a new CEO. Story

> Bausch + Lomb has gained FDA approval for its enVista hydrophobic acrylic intraocular lens. Release

Biotech News

@FierceBiotech: Check out our live coverage of ‪BIO 2012‬ in Boston. More | Follow @FierceBiotech

@JohnCFierce: Tesaro sets IPO terms, looks to raise about $81M, with $25M maybe coming from insiders - I'd like to see this one work. More | Follow @JohnCFierce

@RyanMFierce: Thanks @Millennium_US, Shire, and Biogen for participating on our ‪BIO 2012‬ panel. We drew a crowd and covered a lot. | Follow @RyanMFierce

> Investors offer grim odds of success for two big Alzheimer's programs. Story

> Tesaro insiders pledge support for $86M IPO gamble. Article

> Biotech employment, salaries weather a stormy economic downturn. News

Pharma News

@FiercePharma: Daiichi to take over ‪Ranbaxy‬ unit's marketing in Venezuela, latest 'hybrid biz model' move to make buyout pay off. More | Follow @FiercePharma

> CSL confirms Fluvax manufacturing tied to convulsions in children. News

> Spanish drugmakers hold out their hats to government. More

> Icahn comes back at Forest with 4 board nominees. Story

Drug Delivery News

@DamianFierce: Drugmakers are rethinking drug delivery methods for multiple sclerosis treatments. Report | Follow @DamianFierce

> Notre Dame's nanoparticles effective against drug-resistant cancer. Story

> Ambrx nabs $303M deal with Merck for 'smart bomb' delivery. Article

> TheStreet: Alkermes should stick to drug delivery. More

> Explosive nanocarriers thwart target cells' defenses. News

Biomarkers News

> Blood test for pancreatic cancer may be possible. Story

> Huntington's disease marker emerges in clinical trial. News

> Biodesix feels the buzz at BIO2012. Article

And Finally... The U.S. House of Representatives is scheduled to vote June 20 on a bill that reconciles House and Senate user fee reauthorization bills, The Hill reports. Story

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.